SCHEMBL28043950

SCHEMBL28043950

Cc1cc(C)cc(-c2cc(NCCc3c(C)[nH]c4ccc(C)cc34)nc(N)n2)c1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.43
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
LMNA P02545 3/20 0.43
GAA P10253 3/20 0.43
HRH4 Q9H3N8 6/20 0.43
TLR8 Q9NR97 1/20 0.41
POLB P06746 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
ALOX12 P18054 2/20 0.40
HTT P42858 2/20 0.40
AURKA O14965 1/20 0.40
PDPK1 O15530 1/20 0.40
TGFBR1 P36897 1/20 0.40
AURKB Q96GD4 1/20 0.40
TP53 P04637 3/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15757355 0.83 NUDT1 (0.51) MAPTMEN1KMT2ALMNAGAA
SCHEMBL28151149 0.76 HRH4 (0.64) HRH4TLR8AURKAPDPK1TGFBR1
SCHEMBL28151182 0.75 HRH4 (0.52) HRH4TLR8SMN1; SMN2ALDH1A1
SCHEMBL28043771 0.74 HRH4 (0.62) HRH4TLR8SMN1; SMN2ALDH1A1
SCHEMBL28043933 0.73 HRH4 (0.50) HRH4TLR8SMN1; SMN2ALDH1A1
SCHEMBL28043714 0.73 HRH4 (0.50) HRH4TLR8SMN1; SMN2ALDH1A1
SCHEMBL28043930 0.73 HRH4 (0.55) HRH4TLR8SMN1; SMN2AURKAPDPK1
SCHEMBL28043774 0.72 HRH4 (0.49) HRH4TLR8SMN1; SMN2ALDH1A1
SCHEMBL28043806 0.72 ALDH1A1 (0.52) HRH4TLR8SMN1; SMN2ALDH1A1
SCHEMBL28845266 0.72 CYP2D6 (0.55) MEN1KMT2AGAAHRH4TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105143206-B Pyrimidine -2,4- diamine derivative for treating cancer 托马斯·黑勒戴药物研究基金会 2019-01-15 CN disclosed
CN-105143206-A Pyrimidine-2,4-diamine derivatives for treatment of cancer THOMAS HELLEDAYS STIFTELSE F R MEDICINSK FORSKNING 2015-12-09 CN disclosed